Dr. Alexander Bondoc · DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways
Follow
Article1 min read·Published Dec 2024

DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Dec 2024 · 1 min read

In brief

In brief

This study identifies DNAJB1-PKAc fusion kinase expression in 70% of pediatric hepatoblastoma cases, previously thought exclusive to fibrolamellar carcinoma in adolescents. The fusion kinase drives carcinogenesis by upregulating cell cycle progression genes while suppressing tumor suppressors through β-catenin-mediated pathways.

Written by the GCMD Library team from the article.

Alexander Bondoc

Background and Aims: Hepatoblastoma (HBL) and fibrolamellar hepatocellular carcinoma (FLC) are the most common liver malignancies in children and young adults. FLC oncogenesis is associated with the generation of the fusion kinase, DNAJB1-PKAc (J-PKAc). J-PKAc has been found in 90% of FLC patients' tumors but not in other liver cancers. Since previous studies of J-PKAc were performed with adolescent patients, we asked if young children may express J-PKAc and if there are consequences of such expression. Methods: The biobank of the pediatric HBL/HCN-NOS specimens was examined by QRT-PCR, Western blots, RNA-Seq, and immunostaining with fusion-specific antibodies. Results: J-PKAc is expressed in 70% of the HBL/HCN-NOS patients. RNA-Seq analysis revealed that HBL tumors that do not have cells expressing J-PKAc show elevated expression of the membrane attack complex (MAC), which eliminates cells expressing J-PKAc. The fusion-positive HBL/HCN-NOS samples have several signaling pathways that are different from fusion-negative HBLs. Upregulated pathways included genes involved in the G1 to S transition and in liver cancer. Downregulated pathways included over 60 tumor suppressors, the CYP family, and the SLC family. The repression of these genes involves J-PKAc-β-catenin-TCF4-mediated elevation of the HDAC1-Sp5 pathway. The identified upregulated and downregulated pathways are direct targets of the fusion kinase. The J-PKAc kinase is also detected in livers of 1-year-old children wit

Statements in this article

  1. Hepatoblastoma and fibrolamellar hepatocellular carcinoma are the most common liver malignancies in children and young adults.

    EstablishedBackground and Aims
  2. Fibrolamellar hepatocellular carcinoma oncogenesis is associated with the generation of the fusion kinase DNAJB1-PKAc.

    EstablishedBackground and Aims
  3. DNAJB1-PKAc has been found in 90% of fibrolamellar hepatocellular carcinoma patients' tumors but not in other liver cancers.

    ResearchBackground and Aims
  4. DNAJB1-PKAc is expressed in 70% of hepatoblastoma and hepatocellular carcinoma-NOS patients.

    ResearchResults
  5. Hepatoblastoma tumors that do not have cells expressing DNAJB1-PKAc show elevated expression of the membrane attack complex, which eliminates cells expressing DNAJB1-PKAc.

    ResearchResults
  6. Fusion-positive hepatoblastoma and hepatocellular carcinoma-NOS samples have upregulated pathways including genes involved in the G1 to S transition and in liver cancer.

    ResearchResults
  7. Fusion-positive hepatoblastoma and hepatocellular carcinoma-NOS samples have downregulated pathways including over 60 tumor suppressors, the CYP family, and the SLC family.

    ResearchResults
  8. The repression of tumor suppressors, CYP family, and SLC family genes involves DNAJB1-PKAc-β-catenin-TCF4-mediated elevation of the HDAC1-Sp5 pathway.

    ResearchResults
  9. The DNAJB1-PKAc kinase is detected in livers of 1-year-old children.

    ResearchResults

Read it at the source ↗

Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.